Large grant to investigate monoclonal antibody therapy against COVID-19

To study monoclonal antibody therapy against COVID-19 Joost Wiersinga and Godelieve de Bree will receive a 1.3 million euro grant by NWO and ZonMw.

Global genetics consortium uncovers COVID-19 risk factors

An international collaboration, including researchers from Amsterdam UMC, has identified several host-specific genetic factors associated with SARS-CoV-2 infection and COVID-19 severity.

Strength in numbers through COVID-19

Internist and infectious disease specialist Joost Wiersinga wrote a review of all the scientific medical literature published on COVID-19. The July 2020 JAMA article was an immediate resounding success.

The image of vaccines: why taking a vaccine when it appears to be unsafe?

In the last months, APH researcher Danielle Timmermans shed her light on the communication of the vaccine strategy from the Dutch government.

Research into the use of second vaccination after first Janssen vaccination

Amsterdam UMC, together with three other academic centres, is investigating in the SWITCH study whether a second corona vaccination after a first Janssen vaccination is useful.

Severe COVID-19 patient recovers faster due to leukemia drug imatinib

Research conducted by thirteen large teaching hospitals in the Netherlands suggests that leukemia drug imatinib decrease the duration of mechanical ventilation in the ICU setting in severe COVID-19 patients.

COVID-19 Biobank

The COVID-19 Biobank is set up with the aim to enable as much research as possible in patients with COVID-19. The biobank collects a.o. clinical data, DNA and blood samples from COVID-19 patients hospitalized in Amsterdam UMC.

COVID-19 Task Force Research

To enhance internal coordination between all COVID-19 research activities, Amsterdam UMC have set up five COVID-19 expert groups, which report to the overarching COVID-19 Task Force Research.